(XBIT) - Earnings & Price History

XBIT: - 4.15, $148.76M, -0.11 (-2.58%)

Sector: Healthcare - Industry: Biotechnology

XBiotech, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various diseases. Its lead product is MABp1, which is also known as Xilonix, a novel anti-cancer agent, which has completed Phase III clinical trial in Europe for the treatment of advanced colorectal cancer. MABp1 targets and neutralizes interleukin-1 alpha. XBiotech, Inc. was founded in 2005 and is headquartered in Austin, Texas.Key Statistics

Past XBIT reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-16BMO-0.4216.2815.2915.3215.0116.30.20%6.27%6.47%181.51K
2017-03-09BMO-0.4214.6314.1914.514.2414.752.18%0.90%3.10%42.06K
2016-11-15BMO-0.4615.1814.1114.2714.0515.21.13%▲6.38%7.58%258.06K
2016-08-16BMO-0.3515.1914.4614.441415.44-0.14%5.19%5.05%252.98K
2016-07-29BMO-0.3514.2714.0513.913.914.42-1.07%2.66%1.57%68.35K
2016-07-28BMO-0.3514.0514.0814.513.7314.582.98%-3.10%-0.21%141.29K
2016-07-27BMO-0.3514.0813.8313.7413.6514.1-0.65%2.47%1.81%115.91K
2016-07-26BMO-0.3513.8313.913.6613.6514.15-1.73%1.24%-0.50%178.67K
2016-05-18BMO15.0114.0414.0514.0515.620.07%6.83%6.91%168.63K
2016-03-22-0.359.368.948.998.659.490.56%4.12%4.70%72.37K
2015-11-1214.114.1314.313.8714.281.20%▲-1.40%-0.21%56.72K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades